A 34-Year-Old Male Intravenous Drug User with a Third Episode of Tricuspid Valve Endocarditis Treated with Repeat Valve Surgery

Jeffrey W. Cannon; J.W. Awori Hayanga; Thomas B. Drvar; Matthew Ellison; Christopher Cook; Muhammad Salman; Harold Roberts; Vinay Badhwar; Heather K. Hayanga

doi:10.12659/AJCR.927385

29 March 2021: Articles

A 34-Year-Old Male Intravenous Drug User with a Third Episode of Tricuspid Valve Endocarditis Treated with Repeat Valve Surgery

Unusual clinical course

Jeffrey W. Cannon ^B* , J.W. Awori Hayanga ^A , Thomas B. Drvar ^B , Matthew Ellison ^E , Christopher Cook ^A , Muhammad Salman ^A , Harold Roberts ^A , Vinay Badhwar ^E , Heather K. Hayanga ^A

DOI: 10.12659/AJCR.927385

Am J Case Rep 2021; 22:e927385

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

View HTML version

Table 1. Timeline of surgical operations, pathology findings, reported intravenous drug use, and urine toxicology findings.

	Date	Method	Specimen grown from valve	IV drugs relapse	Opiates on urine drug screening
Operation 1	9/23/18	Autologous tricuspid valve repair	Aggregatibacter segnis, haemophilus parainfluenzae, and eikenella corrodens	No	Performed at OSH
Operation 2	1/21/19	Tricuspid valve replacement with St Jude Epic 29 mm	Mitis group viridans streptococcus	No	Negative
Operation 3	4/1/19	Tricuspid valve replacement with St Jude Epic 31 mm		No	Positive

Back to the Article

A 34-Year-Old Male Intravenous Drug User with a Third Episode of Tricuspid Valve Endocarditis Treated with Repeat Valve Surgery

Your Privacy